Nanostructured materials as potent platforms for cancer chemoimmunotherapy
Advances in Radiotherapy & Nuclear Medicine · 2025
DOI: 10.36922/arnm.8150 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Radiotherapy & Nuclear Medicine, 2025. Verfasst von Himani Kalita und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Combinatorial chemoimmunotherapy has emerged as a potent approach in cancer treatment, offering the advantages of combining two treatment strategies (i.e., chemotherapy and immunotherapy), thereby reducing drug dosages and improving therapeutic outcomes. Nanomaterial-assisted drug delivery systems have garnered significant attention in chemoimmunotherapy for encapsulating and delivering therapeutic agents, as they can simultaneously target both cancer and immune cells, promoting drug accumulation with excellent therapeutic efficacy and minimal toxic side effects. This mini-review focuses on various aspects of immunotherapy and chemoimmunotherapy in cancer treatment and discusses several nanomaterial-assisted drug delivery systems used in chemoimmunotherapy.
Zitieren
APA
Kalita, H., & Patowary, M. (2025). Nanostructured materials as potent platforms for cancer chemoimmunotherapy. Advances in Radiotherapy & Nuclear Medicine. https://doi.org/10.36922/arnm.8150
Vancouver
Kalita H, Patowary M. Nanostructured materials as potent platforms for cancer chemoimmunotherapy. Advances in Radiotherapy & Nuclear Medicine. 2025. doi:10.36922/arnm.8150
BibTeX
@article{Kalita2025,
author = {Kalita, Himani and Patowary, Manoj},
title = {Nanostructured materials as potent platforms for cancer chemoimmunotherapy},
journal = {Advances in Radiotherapy & Nuclear Medicine},
year = {2025},
doi = {10.36922/arnm.8150}
}
EUVIMED